Capital Performance Advisors LLP Voyager Therapeutics, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 16 shares of VYGR stock, worth $112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VYGR
# of Institutions
128Shares Held
36.5MCall Options Held
48KPut Options Held
36.2K-
Black Rock Inc. New York, NY5.31MShares$37.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$36.4 Million0.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$27.4 Million1.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$21.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$16 Million0.09% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $271M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...